Compagnie Lombard Odier S Cm A Selecta Biosciences Inc Transaction History

Compagnie Lombard Odier S Cm A

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.18 - $2.84 $20,710 - $26,980	-9,500 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$8.97 - $23.38 $22,425 - $58,450	-2,500 Reduced 20.83%	9,500 $93,000
Q3 2017 Nov 14, 2017	BUY	$15.22 - $20.03 $182,640 - $240,360	12,000	12,000 $219,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.